ScreenPro Security Inc. (SCRSF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 249.05 Thousand USD | 504.78% |
| 2022 | 41.18 Thousand USD | -27.48% |
| 2021 | 56.78 Thousand USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 124.03 Thousand USD | 111.65% |
| 2024 Q2 | 154.34 Thousand USD | -51.25% |
| 2023 Q3 | 4.75 Million USD | 35558.72% |
| 2023 FY | 249.05 Thousand USD | 504.78% |
| 2023 Q4 | 249.05 Thousand USD | -94.76% |
| 2023 Q2 | 13.33 Thousand USD | -32.34% |
| 2023 Q1 | 19.7 Thousand USD | -52.16% |
| 2022 Q3 | 530.03 Thousand USD | -2.65% |
| 2022 Q1 | 58.52 Thousand CAD | 3.07% |
| 2022 Q4 | 41.18 Thousand USD | -92.23% |
| 2022 FY | 41.18 Thousand USD | -27.48% |
| 2022 Q2 | 544.44 Thousand CAD | 830.26% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q4 | 56.78 Thousand USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2020 Q3 | 95.69 Thousand CAD | 10.38% |
| 2020 Q2 | 86.69 Thousand CAD | 11.58% |
| 2020 Q1 | 77.69 Thousand CAD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2020 Q4 | - CAD | -100.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -4050.833% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | 80.806% |
| Biocept, Inc. | 10.37 Million USD | 97.6% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 99.515% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 99.593% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | 54.413% |
| iMD Companies, Inc. | 1.1 Million USD | 77.434% |
| IDenta Corp. | 428.17 Thousand USD | 41.835% |
| Interpace Biosciences, Inc. | 4.24 Million USD | 94.13% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | 10.414% |
| NovelStem International Corp. | 3.32 Million USD | 92.509% |
| Optigenex Inc. | 4.42 Million USD | 94.374% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | 84.73% |
| Response Genetics, Inc | 4.91 Million USD | 94.936% |
| Rennova Health, Inc. | 359.19 Thousand USD | 30.664% |
| RushNet, Inc. | 4.25 Million USD | 94.143% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | 68.808% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | 56.791% |
| Todos Medical Ltd. | 33 Million USD | 99.245% |